Shamoun Fadi Elias, Fankhauser Grant T, Mookadam Martina
Department of Carviovascular Medicine, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA.
Prim Care. 2013 Mar;40(1):169-77. doi: 10.1016/j.pop.2012.11.001. Epub 2012 Dec 21.
The medical management of patients with an abdominal aortic aneurysm (AAA) includes modification of risk factors, smoking cessation, cardiovascular risk treatment, and hypertensive therapy. No specific therapy has been shown to alter disease outcome. Many AAA and thoracic aortic aneurysms are amenable to endovascular treatment. Endovascular repair offers the benefit of shorter hospital stays and lower perioperative morbidity and mortality. Most patients with peripheral arterial disease (PAD) are asymptomatic or have atypical symptoms; only a few present with classic intermittent claudication or critical limb ischemia. Smoking and diabetes mellitus are the most important risk factors for developing PAD.
腹主动脉瘤(AAA)患者的药物治疗包括改变危险因素、戒烟、心血管风险治疗和高血压治疗。尚无特定治疗方法被证明可改变疾病转归。许多腹主动脉瘤和胸主动脉瘤适合进行血管内治疗。血管内修复具有住院时间短、围手术期发病率和死亡率低的优点。大多数外周动脉疾病(PAD)患者无症状或有非典型症状;只有少数患者表现为典型的间歇性跛行或严重肢体缺血。吸烟和糖尿病是发生外周动脉疾病最重要的危险因素。